Impact of l-arginine supplementation on quality of life in patients with heart failure: a meta-analysis of randomized controlled trials

19 May 2025 (10:00 - 10:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Anthony Jay Alvez

Dr. HB Calleja Heart and Vascular Institute, Quezon City (Philippines)

5 More presentations in this session

Presentation thumbnail

Real-world use and effectiveness of patiromer among patients with heart failure at high risk of hyperkalaemia: insights from the CARE-HK in HF registry

Doctor A. Sauer (Kansas City, US)

Abstract Slides Video

Presentation thumbnail

Safety and efficacy of early initiation of sodium-glucose co-transporter inhibitors 2 in patients hospitalized for acute heart failure: a meta-analysis of randomized controlled trials

Doctor R. Laborante (Stockholm, SE)

Abstract Slides Video

Presentation thumbnail

Sodium-glucose co-transporter-2 inhibitors: prognostic benefit in real-world, elderly, comorbid HFmrEF and HFpEF patients

Mrs S. Valdivielso (Barcelona, ES)

Abstract Slides Video

Presentation thumbnail

Diuretic resistance and the efficacy of hydrochlorothiazide in acute decompensated heart failure: a post-hoc analysis of the CLOROTIC Trial

Doctor A. Pandey (Dallas, US)

Abstract Slides Video

Presentation thumbnail

Serum digoxin concentrations in patients with heart failure: a post-hoc analysis of the BIOSTAT-CHF study

Mr D. Baron (Groningen, NL)

Abstract Slides Video

Access the full session

Session thumbnail

Diverse pharmacological progress in heart failure

The Event

Event poster

Heart Failure 2025

19 May 2025 10:00 CET

You may be interested in

Congress Session

Late breaking clinical trials: drugs and devices

Congress Session

Trials, trends and global insights

Congress Session

Heart Failure 2023 highlights

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources